Have a personal or library account? Click to login
Postponed effect of neostigmine on oxidative homeostasis Cover

Postponed effect of neostigmine on oxidative homeostasis

Open Access
|Dec 2014

References

  1. Akinci SB, Ulu N, Yondem OZ, Firat P, Guc MO, Kanbak M and Aypar U. (2005). Eff ect of neostigmine on organ injury in murine endotoxemia: Missing facts about the cholinergic anti infl ammatory pathway. World JSurg 29: 1483-1489.
  2. Ananth C, Dheen ST, Gopalakrishnakone P and Kaur C. (2001). Domoic acidinduced neuronal damage in the rat hippocampus: Changes in apoptosis related genes (bcl-2, bax, caspase-3) and microglial response. J Neurosci Res 66: 177-190.
  3. Bordonaba JG and Terry LA. (2012). Electrochemical behaviour of polyphenol rich fruit juices using disposable screen-printed carbon electrodes: Towards a rapid sensor for antioxidant capacity and individual antioxidants. Talanta 90: 38-45.
  4. Bucaretchi F, Prado CC, Branco MM, Soubhia P, Metta GM, Mello SM, de Capitani EM, Lanaro R, Hyslop S, Costa JL, Fernandes LCR and Vieira RJ. (2012). Poisoning by illegal rodenticides containing acetylcholinesterase inhibitors (chumbinho): a prospective case series. Clin Toxicol 50: 44-51.
  5. Burnell AM and Wilkins NP. (1988). An investigation of the in vitro inhibition of acetylcholinesterase by the carbamate inhibitor eserine sulphate in eserine resistant strains of Drosophila melanogaster. Comp Biochem Physiol C 90: 215-220.
  6. Cannard K. (2006). The acute treatment of nerve agent exposure. J Neurol Sci 249: 86-94.
  7. Chen Y. (2012). Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies. Neurotoxicity 33: 391-400.
  8. Dahaba AA, Bornemann H, Hopfgartner E, Ohran M, Kocher K, Liebmann M, Wilfi nger G and Metzler H. (2012). Eff ect of sugammadex or neostigmine neuromuscular block reversal on bispectral index monitoring of propofol/ remifentanil anaesthesia. Br J Anaesth 108: 602-606.
  9. Darreh-Shori T and Soininen H. (2010). Eff ects of cholinesterase inhibitors on the activities and protein levels of cholinesterases in the cerebrospinal fluid of patients with Alzheimer’s disease: a review of recent clinical studies.10.2174/15672051079027445520205672
  10. Curr Alzheimer Res 7: 67-73.
  11. de Oliveira P, Gomes AQ, Pacheco TR, de Almeida VV, Saldanha C and Calado A. (2012). Cell-specific regulation of acetylcholinesterase expression under inflammatory conditions. Clin Hemorheol Microcirc 51: 129-137.
  12. Duarte-Salles T, Mendez MA, Morales E, Bustamante M, Rodriguez-Vicente A, Kogevinas M and Sunyer J. (2012). Dietary benzo(a)pyrene and fetal growth: Effect modification by vitamin C intake and glutathione S-transferase P1 polymorphism. Environ Int 45: 1-8.
  13. Ellman GL, Courtney KD, Andres V, Jr. and Feather-Stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.
  14. Foy DS, Trepanier LA and Shelton GD. (2011). Cholinergic crisis after neostigmine administration in a dog with acquired focal myasthenia gravis. J Vet Emerg Crit Care 21: 547-551.
  15. Giadinis ND, Raikos N, Loukopoulos P, Malliarakis E and Karatzias H. (2009). Carbamate poisoning in a dairy goat herd: Clinicopathological fi ndings and therapeutic approach. N Z Vet J 57: 392-394.
  16. Granados-Oliveros G, Gomez-Vidales V, Nieto-Camacho A, Morales-Serna JA, Cardenas J and Salmon M. (2013). Photoproduction of H2O2 and hydroxyl radicals catalysed by natural and super acid-modifed montmorillonite and its oxidative role in the peroxidation of lipids. RSC Adv 3: 937-944.
  17. Granot E, Golan D, Rivkin L and Kohen R. (1999). Oxidative stress in healthy breast fed versus formula fed infants. Nutr Res 19: 869-879.
  18. Gupta RC, Milatovic D and Dettbarn WD. (2001). Depletion of energy metabolites following acetylcholinesterase inhibitor-induced status epilepticus: Protection by antioxidants. Neurotoxicology 22: 271-282.
  19. Haines SR and Thurtell MJ. (2012). Treatment of ocular myasthenia gravis. Curr Treat Option N 14: 103-112.
  20. Harris LW, Talbot BG, Lennox WJ and Anderson DR. (1989). The relationship between oxime-induced reactivation of carbamylated acetylcholinesterase and antidotal effi cacy against carbamate intoxication. Toxicol Appl Pharmacol 98: 128-133.
  21. Johnson EK, Iqbal A, Crombie N, Sharih G and Russell S. (2011). A comparison of the effi cacy and side eff ects of neostigmine and sugammadex in the reversal of non-depolarising muscle relaxants. Anaesthesia 66: 54-54.
  22. Juranek I and Bezek S. (2005). Controversy of free radical hypothesis: reactive oxygen species--cause or consequence of tissue injury? General physiology and biophysics 24: 263-278.
  23. Klinkerberg I, Sambeth A and Blokland A. (2011). Acetylcholine and attention. Behav Brain Res 221: 430-442.
  24. Lederer W, Reiner T and Khuenl-Brady KS. (2010). Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function. J Clin Anesth 22: 420-424.
  25. Luchtemberg MN, Petronilho F, Constantino L, Gelain DP, Andrades M, Ritter C, Moreira JC, Streck EL and Dal-Pizzol F. (2008). Xanthine oxidase activity in patients with sepsis. Clin Biochem 41: 1186-1190.
  26. Marrs TC. (1993). Organophosphate poisoning. Pharmacol Ther 58: 51-66.
  27. Milatovic D, Gupta RC and Aschner M. (2006). Anticholinesterase toxicity and oxidative stress. TheScientifi cWorld Journal 6: 295-310.
  28. Papandreou C, Schiza SE, Tzatzarakis MN, Kavalakis M, Hatzis CM, Tsatsakis AM, Kafatos AG, Siafakas NM and Tzanakis NE. (2012). Eff ect of Mediterranean diet on lipid peroxidation marker TBARS in obese patients with OSAHS under CPAP treatment: a randomised trial. Sleep Breath 16: 873-879.
  29. Parisi P and Francia A. (2000). A female with central anticholinergic syndrome responsive to neostigmine. Pediatr Neurol 23: 185-187.
  30. Pohanka M. (2011a). Alzheimer’s disease and related neurodegenerative disorders: implication and counteracting of melatonin. J Appl Biomed 9: 185-196.10.2478/v10136-011-0003-6
  31. Pohanka M. (2011b). Cholinesterases, a target of pharmacology and toxicology. Biomed Pap 155: 219-229.10.5507/bp.2011.03622286807
  32. Pohanka M. (2012a). Acetylcholinesterase inhibitors: a patent review (2008 - present). Expert Opin Ther Pat 22: 871-886.10.1517/13543776.2012.70162022768972
  33. Pohanka M. (2012b). Alpha7 nicotinic acetylcholine receptor is a target in pharmacology and toxicology. Int J Mol Sci 13: 2219-2238.10.3390/ijms13022219329201822408449
  34. Pohanka M. (2013). Cholinesterases in biorecognition and biosensor construction, a review. Anal Lett 46: 1849-1868.
  35. RamaRao G, Bhattacharya BK, Kumar S and Waghmare CK. (2011). Gene expression and phosphoprotein profile of certain key neuronal signaling proteins following soman intoxication. Toxicology 290: 195-202.
  36. Rodriguez-Naranjo MI, Moya ML, Cantos-Villar E and Garcia-Parrilla MC. (2012). Comparative evaluation of the antioxidant activity of melatonin and related indoles. J Food Compos Anal 28: 16-22.
  37. Starec M, Sinet M, Kodym P, Rosina J, Fiserova A, Desforges B and Rouveix B. (1997). The eff ect of drugs on the mortality of mice inoculated with Friend leukaemia virus or toxoplasma gondii. Physiol Res 46: 107-111.
  38. Tao LY, Chen XP, Qin ZH and Bian SZ. (2006). Could NF-kappa B and caspase-3 be markers for estimation of post-interval of human traumatic brain injury? Forensic SciInt 162: 174-177.10.1016/j.forsciint.2006.06.02116854541
  39. Wang J, Yuan XP, Sun BG and Cao YP. (2011). Inhibition of lipid peroxidation by enzymatic hydrolysates from wheat bran. Food Technol Biotechnol 49: 481-488.
  40. Yang L, Chen JH, Xu T, Zhou AS and Yang HK. (2012). Rice protein improves oxidative stress by regulating glutathione metabolism and attenuating oxidative damage to lipids and proteins in rats. Life Sci 91: 389-394.
DOI: https://doi.org/10.2478/intox-2014-0018 | Journal eISSN: 1337-9569 | Journal ISSN: 1337-6853
Language: English
Page range: 134 - 138
Submitted on: May 2, 2014
|
Accepted on: Aug 29, 2014
|
Published on: Dec 30, 2014
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2014 Miroslav Pohanka, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.